Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide Effects on Bone Microarchitecture
NCT00557310Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2007
- Primary completion
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 4 trial of teriparatide in osteoporosis, sponsored by Eli Lilly and Company. Started Nov 2007; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00557310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00557310.